المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

المؤلفون: Vollenhoven B.J., Healy D.L.

مصطلحات الفهرس: mastalgia/si [Side Effect], multiple pregnancy/si [Side Effect], nausea/si [Side Effect], oral drug administration, ovary hyperstimulation/si [Side Effect], ovary polycystic disease, ovulation induction, pelvis pain syndrome/si [Side Effect], priority journal, review, subcutaneous drug administration, visual impairment/si [Side Effect], chorionic gonadotropin/ad [Drug Administration], chorionic gonadotropin/do [Drug Dose], clomifene citrate/ae [Adverse Drug Reaction], clomifene citrate/ad [Drug Administration], clomifene citrate/do [Drug Dose], clomifene citrate/pd [Pharmacology], estradiol/ec [Endogenous Compound], gonadorelin/ae [Adverse Drug Reaction], gonadorelin/ad [Drug Administration], gonadorelin/do [Drug Dose], gonadorelin/pd [Pharmacology], gonadotropin/ae [Adverse Drug Reaction], gonadotropin/do [Drug Dose], gonadotropin/pd [Pharmacology], human menopausal gonadotropin, luteinizing hormone, recombinant follitropin, human, anovulation, depression/si [Side Effect], dose response, drug hypersensitivity/si [Side Effect], drug mechanism, female, gynecologic cancer/si [Side Effect], hair loss/si [Side Effect], headache/si [Side Effect], hot flush/si [Side Effect], hypogonadotropic hypogonadism, hypothalamus hypophysis gonad system, intramuscular drug administration, intravenous drug administration, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33693
Click here for full text options
LibKey Link

المؤلفون: Burge M., Vasey P.A., Coulthard A., Smith G., Griffin M., Rose S., Lickliter J.D., Francesconi A.B., Milne R., McCarron J., Yeadon T., Wilks A., Cubitt A., Wyld D.K.

مصطلحات الفهرس: multiple cycle treatment, nausea/si [Side Effect], neutropenia/si [Side Effect], phase 1 clinical trial, priority journal, proteinuria/si [Side Effect], QT prolongation/si [Side Effect], randomized controlled trial, side effect/si [Side Effect], solid tumor/dt [Drug Therapy], thrombocytopenia/si [Side Effect], treatment response, visual impairment/si [Side Effect], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/pk [Pharmacokinetics], antineoplastic agent/pd [Pharmacology], caspase, cytokeratin 18/ec [Endogenous Compound], unclassified drug, von Willebrand factor/ec [Endogenous Compound], cyt997/ae [Adverse Drug Reaction], cyt997/ct [Clinical Trial], cyt997/do [Drug Dose], cyt997/dt [Drug Therapy], cyt997/iv [Intravenous Drug Administration], cyt997/pk [Pharmacokinetics], cyt997/pd [Pharmacology], male, abdominal pain/si [Side Effect], adult, advanced cancer, aged, anemia/si [Side Effect], area under the curve, article, clinical article, clinical trial, controlled clinical trial, controlled study, creatinine blood level, cytotoxicity, drug dose escalation, drug half life, drug mechanism, drug metabolism, drug safety, drug tolerability, dyspnea/si [Side Effect], female, headache/si [Side Effect], human, hypertension/si [Side Effect], hypoxia/si [Side Effect], lymphocytopenia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31040
Click here for full text options
LibKey Link

المؤلفون: Bowden S., Marinos G., Reed W., Warner S., De Solom R., Sievert W., Bhathal P., Batey R., Mollison L., Pianko S., Mcdonald J.

مصطلحات الفهرس: human, hypothyroidism/si [Side Effect], immunotherapy, infection rate, irritability, major clinical study, male, mental instability/si [Side Effect], monotherapy, myalgia/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], priority journal, randomized controlled trial, rash/si [Side Effect], relapse, side effect/si [Side Effect], symptomatology, thrombocytopenia/si [Side Effect], tonsillitis/si [Side Effect], urticaria/si [Side Effect], visual impairment/si [Side Effect], alpha2b interferon/ae [Adverse Drug Reaction], alpha2b interferon/ct [Clinical Trial], alpha2b interferon/cb [Drug Combination], alpha2b interferon/cm [Drug Comparison], alpha2b interferon/do [Drug Dose], alpha2b interferon/dt [Drug Therapy], interferon/ae [Adverse Drug Reaction], interferon/ct [Clinical Trial], interferon/cm [Drug Comparison], interferon/do [Drug Dose], interferon/dt [Drug Therapy], placebo, recombinant alpha2b interferon/ae [Adverse Drug Reaction], recombinant alpha2b interferon/ct [Clinical Trial], recombinant alpha2b interferon/cb [Drug Combination], recombinant alpha2b interferon/cm [Drug Comparison], recombinant alpha2b interferon/dt [Drug Therapy], ribavirin/ae [Adverse Drug Reaction], ribavirin/ct [Clinical Trial], ribavirin/dt [Drug Therapy], recombinant alpha2b interferon/do [Drug Dose], adult, anemia/si [Side Effect], article, blood toxicity/si [Side Effect], cholecystitis/si [Side Effect], chronic hepatitis/dt [Drug Therapy], clinical trial, confidence interval, controlled clinical trial, controlled study, depression/si [Side Effect], double blind procedure, drug clearance, drug efficacy, drug megadose, drug mixture, drug safety, drug tolerability, female, flu like syndrome/si [Side Effect], headache/si [Side Effect], hemoglobin determination, hepatitis C/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32777
Click here for full text options
LibKey Link

المؤلفون: Vollenhoven B.J., Healy D.L.

مصطلحات الفهرس: mastalgia/si [Side Effect], multiple pregnancy/si [Side Effect], nausea/si [Side Effect], oral drug administration, ovary hyperstimulation/si [Side Effect], ovary polycystic disease, ovulation induction, pelvis pain syndrome/si [Side Effect], priority journal, review, subcutaneous drug administration, visual impairment/si [Side Effect], chorionic gonadotropin/ad [Drug Administration], chorionic gonadotropin/do [Drug Dose], clomifene citrate/ae [Adverse Drug Reaction], clomifene citrate/ad [Drug Administration], clomifene citrate/do [Drug Dose], clomifene citrate/pd [Pharmacology], estradiol/ec [Endogenous Compound], gonadorelin/ae [Adverse Drug Reaction], gonadorelin/ad [Drug Administration], gonadorelin/do [Drug Dose], gonadorelin/pd [Pharmacology], gonadotropin/ae [Adverse Drug Reaction], gonadotropin/do [Drug Dose], gonadotropin/pd [Pharmacology], human menopausal gonadotropin, luteinizing hormone, recombinant follitropin, human, anovulation, depression/si [Side Effect], dose response, drug hypersensitivity/si [Side Effect], drug mechanism, female, gynecologic cancer/si [Side Effect], hair loss/si [Side Effect], headache/si [Side Effect], hot flush/si [Side Effect], hypogonadotropic hypogonadism, hypothalamus hypophysis gonad system, intramuscular drug administration, intravenous drug administration, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33693
LibKey Link

المؤلفون: Burge M., Vasey P.A., Coulthard A., Smith G., Griffin M., Rose S., Lickliter J.D., Francesconi A.B., Milne R., McCarron J., Yeadon T., Wilks A., Cubitt A., Wyld D.K.

مصطلحات الفهرس: multiple cycle treatment, nausea/si [Side Effect], neutropenia/si [Side Effect], phase 1 clinical trial, priority journal, proteinuria/si [Side Effect], QT prolongation/si [Side Effect], randomized controlled trial, side effect/si [Side Effect], solid tumor/dt [Drug Therapy], thrombocytopenia/si [Side Effect], treatment response, visual impairment/si [Side Effect], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/pk [Pharmacokinetics], antineoplastic agent/pd [Pharmacology], caspase, cytokeratin 18/ec [Endogenous Compound], unclassified drug, von Willebrand factor/ec [Endogenous Compound], cyt997/ae [Adverse Drug Reaction], cyt997/ct [Clinical Trial], cyt997/do [Drug Dose], cyt997/dt [Drug Therapy], cyt997/iv [Intravenous Drug Administration], cyt997/pk [Pharmacokinetics], cyt997/pd [Pharmacology], male, abdominal pain/si [Side Effect], adult, advanced cancer, aged, anemia/si [Side Effect], area under the curve, article, clinical article, clinical trial, controlled clinical trial, controlled study, creatinine blood level, cytotoxicity, drug dose escalation, drug half life, drug mechanism, drug metabolism, drug safety, drug tolerability, dyspnea/si [Side Effect], female, headache/si [Side Effect], human, hypertension/si [Side Effect], hypoxia/si [Side Effect], lymphocytopenia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31040
LibKey Link

المؤلفون: Bowden S., Marinos G., Reed W., Warner S., De Solom R., Sievert W., Bhathal P., Batey R., Mollison L., Pianko S., Mcdonald J.

مصطلحات الفهرس: human, hypothyroidism/si [Side Effect], immunotherapy, infection rate, irritability, major clinical study, male, mental instability/si [Side Effect], monotherapy, myalgia/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], priority journal, randomized controlled trial, rash/si [Side Effect], relapse, side effect/si [Side Effect], symptomatology, thrombocytopenia/si [Side Effect], tonsillitis/si [Side Effect], urticaria/si [Side Effect], visual impairment/si [Side Effect], alpha2b interferon/ae [Adverse Drug Reaction], alpha2b interferon/ct [Clinical Trial], alpha2b interferon/cb [Drug Combination], alpha2b interferon/cm [Drug Comparison], alpha2b interferon/do [Drug Dose], alpha2b interferon/dt [Drug Therapy], interferon/ae [Adverse Drug Reaction], interferon/ct [Clinical Trial], interferon/cm [Drug Comparison], interferon/do [Drug Dose], interferon/dt [Drug Therapy], placebo, recombinant alpha2b interferon/ae [Adverse Drug Reaction], recombinant alpha2b interferon/ct [Clinical Trial], recombinant alpha2b interferon/cb [Drug Combination], recombinant alpha2b interferon/cm [Drug Comparison], recombinant alpha2b interferon/dt [Drug Therapy], ribavirin/ae [Adverse Drug Reaction], ribavirin/ct [Clinical Trial], ribavirin/dt [Drug Therapy], recombinant alpha2b interferon/do [Drug Dose], adult, anemia/si [Side Effect], article, blood toxicity/si [Side Effect], cholecystitis/si [Side Effect], chronic hepatitis/dt [Drug Therapy], clinical trial, confidence interval, controlled clinical trial, controlled study, depression/si [Side Effect], double blind procedure, drug clearance, drug efficacy, drug megadose, drug mixture, drug safety, drug tolerability, female, flu like syndrome/si [Side Effect], headache/si [Side Effect], hemoglobin determination, hepatitis C/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32777
LibKey Link